-
-
-
-
-
-
-
VivoPower completes $41 million Norway data center acquisition
-
-
-
-
-
-
-
Meridian Bioscience (VIVO) Prelim. Q3 Revenue Misses Consensus
-
-
-
-
-
-
-
Meridian Bioscience Names Andy Kitzmiller as Chief Financial Officer
-
-
-
-
-
-
-
Meridian Bioscience (VIVO) Tops Q4 EPS by 3c
-
-
-
-
-
-
-
Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
-
-
-
-
-
-
-
Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021
-
-
-
-
-
-
-
Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission
-
1,222,631 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

